TABLE 2

Pulmonary outcomes three months after hospitalisation

NAllICU admission (n=15)No ICU admission (n=88)p
Spirometry103
 FVC, L3.6 (2.1, 6.0)3.8 (3.2, 5.1)3.6 (3.0, 4.4)0.392
 FVC, % of predicted94 (76, 121)92 (81, 110)95 (87, 108)0.730
 FVC, z-score−0.39 (−0.81, 0.37)−0.58 (−1.34, 0.19)−0.33 (−0.80, 0.42)0.457
 FVC<LLN, n (%)7 (7)2 (13)5 (6)0.269
 FEV1, L2.8 (2.2, 3.3)2.9 (2.5, 3.9)2.7 (2.2, 3.2)0.119
 FEV1, % of predicted92 (84, 106)93 (82, 112)92 (84, 106)0.706
 FEV1, z-score−0.51 (−1.11, 0.32)−0.54 (−1.2, 0.67)−0.50 (−1.11, 0.22)0.973
 FEV1<LLN, n (%)11 (11)2 (13)9 (10)0.661
 FEV1/FVC, %0.77 (0.73, 0.81)0.79 (0.76, 0.85)0.76 (0.72, 0.81)0.049
Gas diffusion102
 DLCO, mmol/kPa/min6.8 (5.7, 8.8)7.9 (5.2, 9.4)6.7 (5.7, 8.3)0.794
 DLCO, % of predicted83 (72, 92)83 (66, 86)83 (72, 94)0.278
 DLCO, z-score−0.86 (−1.52, −0.06)−0.74 (−1.04, −0.60)−0.88 (−1.54, 0.02)0.279
 DLCO <LLN, n (%)24 (24)4 (29)20 (23)0.735
 DLCO/VA, mmol/kPa/min·L−11.39 (1.16, 1.54)1.34 (1.18, 1.55)1.39 (1.16 1.53)0.876
 DLCO/VA, % of predicted95 (83, 105)95 (94, 97)96 (95, 98)0.899
 DLCO/VA, z-score−0.28 (−1.13, 0.39)−0.46 (−0.90, 0.09)−0.17 (−1.17, 0.41)0.915
Dyspnoea, oxygen saturation and exercise capacity
 Dyspnoea, mMRC >0, n (%)6937 (54)5 (42)32 (56)0.526
 Peripheral oxygen saturation at rest, %7496 (95–97)95 (94, 97)96 (95, 98)0.283
 6-minute walking distance, m73580 (500, 640)615 (441, 705)588 (500, 640)0.540
Chest CT100
 Ground-glass opacities >10% in at least one zone, n (%)25 (25)6 (43)19 (22)0.108
 Parenchymal bands, n (%)19 (19)5 (36)14 (16)0.134

Median (25–75th percentile) unless specified otherwise.

CT: computed tomography; DLCO: diffusion capacity of carbon monoxide; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; ICU: intensive care unit; LLN: lower limits of normal; mMRC: modified Medical Research Council Dyspnea Scale; VA: alveolar ventilation capacity.